Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  Heart failure

Implantable cardioverter defibrillators in chronic kidney disease

A recent observational study reports that implantable cardioverter defibrillators were not associated with improved survival in patients with heart failure, reduced left ventricular ejection fraction and chronic kidney disease. Further studies are needed to identify which of these high-risk patients are most likely to benefit from this potentially life-saving therapy.

Your institute does not have access to this article

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Fig. 1: Age-specific treatment effects of ICDs in non-ischaemic systolic heart failure.

References

  1. Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E. & Hsu, C. Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351, 1296–1305 (2004).

    Article  PubMed  CAS  Google Scholar 

  2. Chertow, G. M., Normand, S.-L. T. & McNeil, B. J. ‘Renalism’: inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. J Am. Soc. Nephrol. 15, 2462–2468 (2004).

    Article  PubMed  Google Scholar 

  3. Fellstrom, B. C. et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N. Engl. J. Med. 360, 1395–1407 (2009).

    Article  PubMed  CAS  Google Scholar 

  4. Bansal, N. et al. Long-term outcomes associated with implantable cardioverter defibrillator in adults with chronic kidney disease. JAMA Intern. Med. 178, 390–398 (2018).

    Article  PubMed  Google Scholar 

  5. Epstein, A. E. et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. Circulation 117, e350–e408 (2008).

    Article  PubMed  Google Scholar 

  6. Pun, P. H. et al. Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. Kidney Int. 76, 652–658 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Pun, P. H. et al. Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials. Am. J. Kidney Dis. 64, 32–39 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Elming, M. B. et al. Age and outcomes of primary prevention implantable cardioverter-defibrillators in patients with nonischemic systolic heart failure. Circulation 136, 1772–1780 (2017).

    Article  PubMed  Google Scholar 

  9. Goldenberg, I. et al. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the multicenter automatic defibrillator implantation trial II. Circulation 113, 2810–2817 (2006).

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors wish to acknowledge helpful discussions with D. M. Charytan (Brigham and Women’s Hospital, Boston, USA) and B. Claggett (Brigham and Women’s Hospital, Boston, USA) regarding this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marc A. Pfeffer.

Ethics declarations

Competing interests

M.A.P. receives research support from Novartis and serves as a consultant for AstraZeneca, Bayer, Boehringer Ingelheim, DalCor, Genzyme, Gilead, GlaxoSmithKline, Janssen, Lilly, Novartis, Novo Nordisk, Relypsa, Sanofi, Teva and Thrasos. He also has stock options for DalCor. F.R.M. reports no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Mc Causland, F.R., Pfeffer, M.A. Implantable cardioverter defibrillators in chronic kidney disease. Nat Rev Nephrol 14, 357–358 (2018). https://doi.org/10.1038/s41581-018-0007-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41581-018-0007-5

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing